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Abstract: (1) Background: Nutrition is a major lifestyle factor that can prevent the risk of cognitive
impairment and dementia. Diet-induced metabolic endotoxemia has been proposed as a major
root cause of inflammation and these pathways emerge as detrimental factors of healthy ageing.
The aim of this paper was to update research focusing on the relationship between a fat-rich diet and
endotoxemia, and to discuss the potential role of endotoxemia in cognitive performances. (2) Methods:
We conducted a non-systematic literature review based on the PubMed database related to fat-rich
meals, metabolic endotoxemia and cognitive disorders including dementia in humans. A total of
40 articles out of 942 in the first screening met the inclusion criteria. (3) Results: Evidence suggested
that a fat-rich diet, depending on its quality, quantity and concomitant healthy food components,
could influence metabolic endotoxemia. Since only heterogeneous cross-sectional studies are available,
it remains unclear to what extent endotoxemia could be associated or not with cognitive disorders
and dementia. (4) Conclusions: A fat-rich diet has the capability to provide significant increases in
circulating endotoxins, which highlights nutritional strategies as a promising area for future research
on inflammatory-associated diseases. The role of endotoxemia in cognitive disorders and dementia
remains unclear and deserves further investigation.
Keywords: nutrition; dietary fat; high-fat; endotoxemia; lipopolysaccharide; Alzheimer’s disease;
dementia; humans
1. Introduction
As a consequence of the ageing population, the prevalence of dementia, characterized by a
progressive deterioration of cognitive performances in multiple domains (i.e., memory, reasoning,
judgement and ability to perform daily activities) that evolves into a pathological diagnosis, is
increasing [1]. The aetiology of dementia is multi-factorial and consists of a dynamic interaction
between genetic susceptibility, non-modifiable factors (i.e., age and sex), pathological processes and
environmental factors, some of them being potentially preventable [2,3].
In this context, nutrition—a major lifelong environmental factor—is of growing interest and
offers an interesting strategy for the prevention of cognitive decline and subsequent dementia [4].
Numerous studies have suggested a benefit of higher adherence to healthy dietary patterns, with a
beneficial balance in favour of unsaturated fatty acids to the detriment of saturated fatty acids such as
Nutrients 2019, 11, 1887; doi:10.3390/nu11081887 www.mdpi.com/journal/nutrients
Nutrients 2019, 11, 1887 2 of 23
the plant-based Mediterranean diet, on age-related cognitive impairments, whether they are due to
degenerative or vascular origin [5–8].
Conversely, the Western diet, characterized among other factors by a high intake of saturated and
trans fatty acids, has been associated with an increased risk of developing dementia [5,7]. Moreover,
adopting this fat-rich dietary pattern can lead to metabolic disorders such as obesity or Type 2 Diabetes
Mellitus (T2DM), these latter being associated with a higher risk of developing dementia in later
life [9,10].
Nutritional strategies represent a promising area to prevent neurocognitive impairments and
subsequent dementia. While the precise mechanisms underlying the relationships between these
dietary habits on age-related cognitive disorders are not yet completely understood (for instance,
inflammatory pathways, vascular factors, oxidative stress or amyloidogenesis [11–14]), we suggest that
the activation of the innate immune system by endotoxins—which are still poorly described—could be
considered as one potential cellular mechanism involved in these relationships.
Endotoxins (Lipopolysaccharides, LPS), a major component of the outer membrane of Gram-negative
bacteria, are now well as contributors to the inflammation [15]. Although LPS may originate from skin
and mucous membranes or local sites of bacterial infection for instance, the gut microbiota is considered
the main natural reservoir of pro-inflammatory endotoxins in the body [16]. Endotoxins are released
when bacteria die, and then dissociated endotoxins are able to cross the gastro-intestinal barrier to end up
in the bloodstream. The presence of LPS in the bloodstream is defined as endotoxemia. Briefly, the
endotoxic metabolic pathway includes the binding of circulating LPS to LPS-Binding Protein (LBP)
and its transfer to the CD14 receptor, which is present both in a membrane-anchored form (mCD14)
and in a soluble circulating form (sCD14) [17]. The complex LPS–LBP–CD14 initiates the secretion of
pro-inflammatory cytokines, such as Interleukin-6 (IL-6) or Tumor Necrosis Factor α (TNFα), through
a TLR4-dependent mechanism [18].
Although LPS is detectable at low concentrations in the circulation of healthy individuals,
there is evidence that LPS levels transiently increase following ingestion of fat-rich meals [19].
Such endotoxemia is defined as “metabolic endotoxemia”, in contrast to other sources of endotoxemia
such as exogenous bacterial infection or sepsis. For instance, in mice fed with a four-week high-fat
diet, plasma levels of LPS were similar to those observed following a four-week subcutaneous
infusion of 300 µg/kg/day of LPS [20]. Metabolic endotoxemia has been proposed as a major cause of
inflammation, including chronic low-grade inflammation. Indeed, animal and experimental studies
have demonstrated that postprandial state may result in an inflammatory response closely associated
with the increase in the circulating levels of LPS [21,22]. Interestingly, not all dietary interventions lead
to increased metabolic endotoxemia and the associated postprandial inflammatory status. Data from
animal studies have suggested that dietary fats act as the main macronutrients responsible for
postprandial endotoxemia, and that both the quantity and the quality of the dietary fat differentially
influence metabolic endotoxemia [23–25]. Moreover, healthy diets rich in unsaturated fatty acids
have been associated with lower postprandial circulating levels of LPS, closely associated with lower
pro-inflammatory markers. Conversely, the consumption of high-energy or high saturated-fat diets
has been associated with increased postprandial levels of LPS and increased circulating levels of
pro-inflammatory markers [23–25].
Currently, the available literature points out that elevated circulating levels of LPS are detrimental
for healthy ageing. More specifically, elevated levels of LPS have been associated with a large range
of diseases such as obesity, T2DM, coronary artery disease and depression [19]. In the context of
dementia, studies have summarized evidence that neuroinflammation is considered not only an
epiphenomenon of Alzheimer’s disease (AD) but also a triggering factor that contributes to exacerbated
AD pathology [26,27]. In addition, systemic exposure to an overload of endotoxins is widely used in
animal studies to induce neuroinflammation and neurodegeneration and is associated with increased
disruption of the amyloid-β precursor, hyperphosphorylated tau and neuronal cell death, which
are hallmarks of AD [15,28–31]. Based on the biological plausibility taken from animal studies, we
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hypothesized that lifelong exposure to endotoxins, worsened by a chronic consumption of unhealthy
diets rich in saturated fat, might exacerbate the detrimental outcomes of endotoxins in the human brain.
The aim of this paper is therefore to discuss the potential role of endotoxins, as an underappreciated
mechanism that could be involved, at least in part, in the relationship between dietary fat intake and
the pathogenesis of dementia in humans.
This article was thus conducted to emphasize research that focused on two major approaches:
(i) to determine the impact of fat-rich meal intake on postprandial and fasting endotoxemia and then
(ii) to clarify the relationship between LPS and cognitive performances, with a specific emphasis on
dementia or AD wherever possible.
2. Methods
We did not follow the strict methodology described for conducting a systematic literature review;
since not all selected studies were reviewed by the three co-authors, there was no standardized quality
assessment of selected studies and we restricted our research to a single database (i.e., PubMed).
The literature search was conducted and closed in February 2019 to encompass the two main aspects
described above.
We used the following nutritional search terms: “high-fat”, “fat intake”, “dietary fat”, “(un)saturated
fatty acids”, “Western diet”, “(un)healthy diet”, “Mediterranean diet”, “prudent diet” combined with at
least one of the search terms relative to LPS, which included “lipopolysaccharide”, “LPS”, “endotoxin”,
“endotoxemia”. These search terms were applied for the selection of articles related to the approach
focusing on the relation between dietary fat intake and metabolic endotoxemia. Regarding the approach
focusing on the relation between endotoxemia and cognitive performances/dementia, identical search
terms have been applied for LPS, combined with at least one of the following cognition-related terms:
“dementia”, “Alzheimer’s disease”, “cognition”, “memory”, “neurocognitive disorders”. A literature
search was also applied with the combination of all three domain terms (i.e., nutritional AND LPS
AND cognitive terms) to select any article that would concern the whole approach. Other studies were
obtained manually from the reference lists of review or original articles.
Through this research strategy, we identified a total of 942 original articles conducted on human
samples (299 related to the relation between dietary fat intake and metabolic endotoxemia and
643 related to the relation between endotoxemia and cognitive performances/dementia).
Article selection was based on a two-step procedure with a first step selection based on the title
and a second step selection based on the abstract reading. Articles were selected applying the following
inclusion criteria: articles published in English, in scientific journals, original research, conducted on
human samples. Articles including animal studies, in vitro and ex vivo studies, studies on vaccination
with LPS or other pre-treatment with LPS, population aged less than 18 y, systematic review and
meta-analyses were excluded. No restriction was performed on study design or date of publication.
Due to the possible sickness behavior induced by endotoxin injection (e.g., fever, malaise, headache
and so forth) which may influence the subjective aspect of well-being and cognitive feeling, we chose
not to discuss studies about self-reported feelings of the cognitive aspect or mood disorders. Finally,
a total of 40 articles were included to establish this “state-of-the-art” article.
Due to the heterogeneity observed in nutritional intervention studies and regarding the cognitive
domains assessed, no meta-analyses were performed in this article.
3. Results
3.1. Dietary Fat and Endotoxemia
3.1.1. Role of Dietary Fat Interventions on Postprandial Metabolic Endotoxemia
The role of dietary fats is of growing interest among macronutrients in many studies on the link
between nutrition and metabolic endotoxemia. As described below (Table 1), evidence accumulated
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over the past few decades has demonstrated a transient increase in circulating LPS following the
consumption of dietary fats.
Dietary Fats
Deopurkar et al. [32] attempted to determine which macronutrient was responsible for postprandial
metabolic endotoxemia by comparing isocaloric meals (300 kcal) from a glucose-drink, orange juice or
dairy cream among 42 healthy adults. In this study, only dairy cream consumption increased plasma
LPS levels, suggesting that dietary fats act as the main macronutrient responsible for postprandial
endotoxemia. Among healthy men, postprandial LPS was increased by 35% to 50% following a single
acute high-fat bolus [21,33,34].
Amount of Fats
In a comparative study using different caloric doses of a high-fat diet (500, 1000 or 1500 kcal
corresponding to 34 to 102 g of fat), Schwander et al. [35] observed a positive association between fat
caloric doses and increased LPS levels. Along this line, another study found higher postprandial levels
of LPS following ingestion of 40 g of fat compared to 10 g among obese participants [36].
Quality of Fats
More recently, a study suggested that not only the quantity but also the quality of dietary fats may
be of importance. In a randomized crossover study among 20 healthy young adults, Lyte et al. [37]
demonstrated that serum levels of LPS were decreased by 50% following the consumption n-3
polyunsaturated fatty acids (PUFA) and increased by 60% following the consumption of saturated fatty
acids (SFA). A sustained response (until 3 h after meal) was also observed in high-fat diet compared to
low-fat-diet (peak at 1 h after meal).
Structure of Fats
Interestingly, beyond the quantity and quality of fat intake, Vors et al. [38] suggested that the
structure of lipids could also be one of the determinants of metabolic endotoxemia and compared the
effect of 40 g of milk fat, which only differed by fat structure, either spread or emulsified. Compared
with spread fat consumption, emulsified fat consumption induced more pronounced postprandial
levels of LPS in obese subjects.
Supplementation with Healthy Food Components
Acute peanut consumption within a high-fat meal was associated with lower LPS concentrations 3
h postprandially compared with a control biscuit which provided similar quantities of macronutrients,
fibre and energy [39]. This result suggested that the addition of healthy food components to a high-fat
diet could contribute to limiting postprandial metabolic endotoxemia. In this line, Ghanim et al.
demonstrated that the increased levels of LPS following the intake of a high-fat high-calorie meal [40]
could be prevented by the addition of 30 g of fibre, among healthy adults [41]. In parallel, no increase
in postprandial endotoxemia was observed after the consumption of a low-fat meal rich in fibre and
fruit [40]. Using the same high-fat high-calorie meal as Ghanim et al. [40], Milan et al. [42] explored the
postprandial effect of dietary fat intake among healthy younger (20–25 y) and older adults (60–75 y)
and failed to reproduce the postprandial effect observed by Ghanim et al., although a trend for higher
LPS levels was observed with the high-fat high caloric diet. Moreover, no difference in LPS levels was
observed between younger and older adults following meal intake.
Overall, these studies suggested that the matrix effect of foods (i.e., the quantity, the quality, and
structure of the ingested fats and the overall food components of the diet) could be a key component of
the diet intake-related metabolic endotoxemia response, although no report has specifically developed
this hypothesis.
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Metabolic Endotoxemia among Different Disease Phenotypes
The acute effects of dietary fats intake on metabolic endotoxemia among different disease
phenotypes including obesity, impaired glucose tolerance (IGT) and T2DM have also been explored.
Interestingly, the overall results suggested that metabolic endotoxemia was significantly associated
with metabolic health as described below.
In 2012, Harte et al. [43] found that metabolic endotoxemia was exacerbated after dietary fat
intake among individuals with IGT and T2DM compared with non-obese participants. Following the
ingestion of whipping cream, postprandial endotoxin levels were increased by 20% in obese or IGT
subjects and by 125% in T2DM individuals compared with non-obese subjects. Among 40 morbidly
obese adults (i.e., BMI > 40 kg/m2), the ingestion of a fat overload increased levels of LPS in participants
with the highest postprandial hypertriglyceridemia (>80 mg/dL) [44]. More recently, Al-Disi et al. [45]
demonstrated that a high-fat diet (75 g of fat per m2 body surface) exacerbated the postprandial
endotoxemia in normal-weight and T2DM participants, but with a different impact on cardio-metabolic
health: non-diabetic subjects appeared to have better metabolic resistance to the insult of a high-fat
diet as seen by a postprandial increase in triglycerides and insulin and a decrease in HDL and LDL
cholesterol [45].
Overall, evidence suggests that a single high-fat meal, especially one devoid of healthy food
components, has an undoubted capacity to enhance transient postprandial endotoxemia in humans,
this latter finding appears to be more pronounced in metabolically impaired individuals. To date, only
a few studies have investigated the long-term effect of diet on postprandial and fasting levels of LPS,
as described below.
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Table 1. Selective evidence on the association between a single high-fat meal and metabolic endotoxemia.
Clinical Trials
Reference Sample Characteristics EndotoxemiaAssessment Nutritional Characteristics
Analysis
Design Results
Lyte JM. et al., Lipids
Health Dis, 2016 [37] 20 healthy subjects (mean age 25 y, 60% men)
Serum LPS
quantified by LAL
Four meals (35% fat provided from
n-3 PUFA (fish oil), 35% fat
provided from n-6 PUFA
(grapeseed oil), 35% fat provided
from SFA (coconut oil) and 20% fat
(olive oil, control diet))
Randomized
single-blind
crossover study
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obese (mean age 32 y) and 50 T2DM (mean age 42 
y) subjects, all women 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
an  6 g protein per m² body 
surface) 
Randomized 
controlled trial 
     LPS 3 h after high-fat 
meal in the lean 
(compared to baseline) 
and T2DM (compared to 1 
h postprandial) groups 
Vors C  et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in obese 
subjects after 40 g fat 
compared to 10 g fat 
Schwander F. 
et l., J Nutr, 
2014 [35] 
19 no mal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal f a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
LPS with ener y intake in
both groups
No difference in the
dose-response of postprandial
LPS between normal-weight
and obese
Harte AL. et al., Diabetes
Care, 2012 [43]
9 non-obese (mean age 40 y, 50% men), 15 obese (mean age 44 y, 50%
men), 12 imp ired glucose tolerance (IGT, mean age 42 y, 58% men)
and 18 T2DM (mean age 45 y, 61% men) subjects
Serum LPS
quantified by LA
Hi h-fat meal (whipping cream
with 75 g fat, 5 g carbohydrate and
6 g protein per m2 body surface)
Controlled trial
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Lyte JM. et al., 
Lipids Health 
Dis, 2016 [37] 
20 healthy subjects (mean age 25 y, 60% men) 
Serum PS 
quantified by 
LAL 
Four meal  (35% fat provided 
from n-3 PUFA (fish oil), 35% fat 
provided from n-6 PUFA 
(grapeseed oil), 35% fat provided 
from SFA (coconut oil) and 20% 
fat (olive oil, control diet)) 
Rando ized 
sing e-blind 
crossover study 
      LPS until 5 h after n-3 
PUFA meal compared to 
SFA meal 
Al-Disi DA. t 
al., Nutrients, 
2015 [45] 
92 lean controls (mean age 24 y), 24 overweight or 
obese (m an age 32 y) and 50 T2DM (mean age 42 
y) subjects, all women 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Randomize  
contr lled trial 
     LPS 3 h after high-fat 
meal in the lean 
(   baseline) 
and T2DM (compared to 1 
h postprandial) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 r 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in obese 
subjects after 40 g fat 
compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma PS 
quantified by 
LA  
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
cross v r s udy 
      with energy intake 
in both groups  
No diffe nce in the dose-
response of postprandial 
LPS between normal-
weight and bese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baselin  
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
LPS after high-f t diet in
all four groups compared to
baseline
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Lyte JM. et al., 
Lipids Health 
Dis, 2016 [37] 
20 healthy subjects (mean age 25 y, 60% men) 
Serum LPS 
quantified by 
LAL 
Four meals (35% fat provided 
fro  n-3 PUFA (fish oil), 35% fat 
provided from -6 PUFA 
(grapeseed oil), 35% fat provided 
from SFA (coconut oil) and 20% 
fat (olive oil, control diet)) 
Randomized 
single-blin  
crossover study 
      LPS until 5 h after n-3 
PUFA m al compa ed to 
SFA meal 
Al-Disi DA. et 
al., Nutrients, 
2015 [45] 
92 lean c ntrols (mean age 24 y), 24 overweight or 
obese (mean age 32 y) and 50 T DM (m an age 42
y) subjects, all women 
Serum LPS 
quantified by 
LAL 
Hig -fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Randomized 
controlled trial 
     LPS 3 h after high-fat 
meal i  the lean 
(compared to baseline) 
and T2DM (compared to 1 
h stprandial) groups 
Vors C. et al., J 
Clin
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat ( 9% SFA, 28% MUFA and 
3  PUFA) 
Randomized 
crossover study 
     LPS only in ob se 
subjects after 40 g fat 
compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (   41 ) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomize  
crossover study 
     LPS with energy i take 
in both groups  
No differen e in th  dose-
response of postpr n al
LPS betw en n rmal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface
Controlled trial 
     LPS after high-fat di t 
in all four groups 
compared to baseline 
    LPS y 20% in obese 
and IGT and by 125% in 
T2DM subjects compar d 
to non-ob se participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
LPS by 20% in obese and
IGT and by 125% in T2DM
subjects compared to non-obese
participants
Milan AM. et al., Nutrients,
2017 [42]
15 young adults (mean age 23 y, 40% men) and 15 elderly subjects
(mean age 67 y, 40% men)
Plasma LPS
quantified by LAL
High-fat (32% fat) or low-fat (11.5%
fat) meals
Randomized
crossover study
No differenc in LPS lev ls after
high fat diet compared to
baseline
Schmid A. et al., Br J Nutr,
2015 [34]
19 healthy subjects (mean age 42 y, all men) Plasma LPS
quantified by LAL
Three meals (High-fat dairy meal,
High-fat non-dairy meal
supplemented with milk or not, all
60% fat)
Randomized
crossover study
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Lyte JM. et al., 
Lipids Health 
Dis, 2016 [37] 
20 healthy subjects (mean age 25 y, 60% men) 
Serum LPS 
quantified by 
LAL 
Four meals (35% fat provided 
from n-3 PUFA (fish oil), 35% fat 
provided from n-6 PUFA 
(grapeseed oil), 35% fat provided 
from SFA (coconut oil) and 20% 
fat (olive oil, control diet)) 
Randomized 
single-blind 
crossover study 
      LPS until 5 h after n-3 
PUFA meal compared to 
SFA meal 
Al-Disi DA. et 
al., Nutrients, 
2015 [45] 
92 lean controls (mean age 24 y), 24 overweight or 
ob se (m an age 32 y) a d 50 T2DM (mean ag  42 
y) subjects, all women 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Randomized 
controlled trial 
     LPS 3 h after high-fat 
eal in the l a  
(compared to baseline) 
and T2DM (compared to 1 
h postprandial) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in obese 
subjects after 40 g fat 
compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all en 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
LPS after high-fat meal
co are to baseline
No difference in postprandial
LPS levels between the three
meals
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Table 1. Cont.
Clinical Trials
Reference Sample Characteristics EndotoxemiaAssessment Nutritional Characteristics
Analysis
Design Results
Moreira AP. et al., J Hum
Nutr Diet, 2016 [39] 65 overweight and obese subjects (mean age 27 y, all men)
Plasma LPS
quantified by LAL
Three meals (shake with
conventional peanuts CVP,
high-oleic peanuts HOP or control
biscuit CT, all 49% fat)
Controlled trial
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Lyte JM. et al., 
Lipids Health 
Dis, 2016 [37] 
20 healthy subjects (mean age 25 y, 60% men) 
Serum LPS 
quantified by 
LAL 
Four meals (35% fat provided 
from n-3 PUFA (fish oil), 35% fat 
provided from n-6 PUFA 
(grapeseed oil), 35% fat provided 
from SFA (coconut oil) and 20% 
fat (olive oil, control diet)) 
Randomized 
single-blind 
crossover study 
      LPS until 5 h after n-3 
PUFA meal compared to 
SFA meal 
Al-Disi DA. et 
al., Nutrients, 
2015 [45] 
92 lean controls (mean age 24 y), 24 overweight or 
obese (mean age 32 y) and 50 T2DM (mean age 42 
y) subjects, all women 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Randomized 
controlled trial 
     LPS 3 h after high-fat 
meal in the lean 
(compared to baseline) 
and T2DM (compared to 1 
h postprandial) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in obese 
subjects after 40 g fat 
compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
LPS in the CT diet 3 h after
ingestion compared to CVP and
HOP meals
Clemente-Postigo M. et al., J
Lipid Res, 2012 [44]
10 subjects with HOMA-IR ≤ 5 and TG < 80 mg/dL (group 1, mean age
40 y), 10 subjects with HOMA-IR > 8 and TG < 80 mg/dL (group 2,
mean age 39 y), 10 subjects with HOMA-IR ≤ 5 and TG > 80 mg/dL
(group 3, mean age 43 y) and 10 subjects with HOMA-IR > 8 and TG >
80 mg/dL (group 4, mean age 42 y), all morbidly obese subjects
Serum LPS
quantified by LAL
High-fat meal (50% fat) Controlled trial
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Lyte JM. et al., 
Lipids Health 
Dis, 2016 [37] 
20 healthy subjects (mean age 25 y, 60% men) 
Serum LPS 
quantified by 
LAL 
Four meals (35% fat provided 
from n-3 PUFA (fish oil), 35% fat 
provided from n-6 PUFA 
(grap seed oil), 35% fat provided 
from SFA (coconut oil) and 20% 
fat (olive oil, control diet)) 
Randomized 
single-blind 
crossover study 
      LPS until 5 h after n-3 
PUFA meal compared to 
SFA meal 
Al-Disi DA. et 
al., Nutrients, 
2015 [45] 
92 lean controls (mean age 24 y), 24 overweight or 
obese (mean age 32 y) and 50 T2DM (mean age 42 
y) subjects, all wome  
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Randomized 
controlled trial 
     LPS 3 h after high-fat 
meal in the lean 
(compared to baseline) 
and T2DM (compared to 1 
h postprandial) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in obese 
subjects after 40 g fat 
compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
LPS after high-fat meal in
groups 3 and 4 (TG > 80 mg/dL)
compared to baseline
No ifference in LPS levels after
high-fat diet between groups
Deopurkar R. et al.,
Diabetes Care, 2010 [32]
48 healthy subjects (range age 25–47 y) Plasma LPS
quantified by LAL
33 g dairy cream (70% SFA, no
carbohydrate), 75 g glucose-based
drink, orange juice or water
Controlled trial
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Lyte JM. et al., 
Lipids Health 
Dis, 2016 [37] 
20 healthy subjects (mean age 25 y, 60% men) 
Serum LPS 
quantified by 
LAL 
Four meals (35% fat provided 
from n-3 PUFA (fish oil), 35% fat 
provided from n-6 PUFA 
(grapeseed oil), 35% fat provided 
from SFA (coconut oil) and 20% 
fat (olive oil, control diet)) 
Randomized 
sing e-blind 
crossover study 
      LPS until 5 h after n-3 
PUFA meal compared to 
SFA meal 
Al-Disi DA. et 
al., Nutrients, 
2015 [45] 
92 lean controls (mean age 24 y), 24 overweight or 
obese (mean age 32 y) and 50 T2DM (mean age 42 
y) subjects, all women 
Seru  LPS 
quantified by 
L L 
High-fat meal (whipping cream 
with 75 g fat, 5  carbohydrate 
and 6 g protein pe  m² body 
surface) 
ando ized 
controlled trial 
     LPS 3 h after high-fat 
meal in the lean 
(compared to baseline) 
and T2DM (compared to 1 
h postprandial) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in obese 
subjects after 40 g fat 
compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte L. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Seru  LPS 
quantified by 
L L 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
LPS after ingestion of dairy
cream compared to baseline
No difference in LPS levels after
ingestion of glucose-based
drink, o ge juice or water
Ghanim H. et al., Diabetes
Care, 2009 [40]
20 healthy subjects (range age 20–50 y, 75% men) Plasma LPS
quantified by LAL
High-fat high cholesterol HFHC
(42% fat) or American Heart
Association (AHA)-recommended
(27% fat)) meals
Controlled trial
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Lyte JM. et al., 
Lipids Health 
Dis, 2016 [37] 
20 healthy subjects (mean age 25 y, 60% men) 
Serum LPS 
quantified by 
LAL 
Four meals (35% fat provided 
from n-3 PUFA (fish oil), 35% fat 
provided from n-6 PUFA 
(grapeseed oil), 35% fat provided 
from SFA (coconut oil) and 20% 
fat (olive oil, control diet)) 
Randomized 
single-blind 
crossover study 
      LPS until 5 h after n-3 
PUFA meal compared to 
SFA meal 
Al-Disi DA. et 
al., Nutrients, 
2015 [45] 
92 lean controls (mean age 24 y), 24 overweight or 
obese (mean age 32 y) and 50 T2DM (mean age 42 
y) subjects, all women 
Serum LPS 
quantified by 
LAL 
Hig -fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Randomized 
controlled trial 
     LPS 3 h after high-fat 
meal in the lean 
(compa ed to b sel ne) 
and T2DM (compared to 1 
h postprandi l) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36]
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS onl  in obese 
subjects after 40 g fat
compared to 10 g fat
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS wit  energy in ake 
in bo h groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
LPS after HFHC meal
compared to baseline
No difference in LPS levels after
AHA diet c mpared to baseline
Ghanim H. et al., J Clin
Endocrinol Metab, 2017 [41]
10 heal hy subjects (mean age 33 y, 60% men) Plasma LPS
quantified by LAL
High-fat high-c rbohyd ate HFHC
meal (42% fat) with or without
additional 30 g of fibre
Randomized
crossover study
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Al-Disi DA. et 
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2015 [45] 
92 lean controls (mean age 24 y), 24 overweight or 
obese (mean age 32 y) and 50 T2DM (mean age 42 
y) subj cts, all women 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Randomized 
controlled trial 
     LPS 3 h after high-fat 
meal in the lean 
(compared to baseline) 
and T2DM (compared to 1 
h postprandial) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in obese 
subjects after 40 g fat 
compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
LPS after HFHC meal
No difference in postprandial
LPS levels with additional 30 g
of fibre to the HFHC
Erridge C. et al., Am J Clin
Nutr, 2007 [33] 12 healthy subjects (mean age 32 y), all men
Plasma LPS
quantified by LAL
High-fat meal (toast with 50 g
butter)
Ra domized
crossover study LPS after high-fat meal
Laugerette F. et al., J Nutr
Biochem, 2011 [21] 12 healthy subjects (mean age 27 y, all men)
Plasma LPS
quantified by LAL Mixed meal (33% fat) Controlled trial
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from n-3 PUFA (fish oil), 35% fat 
provided from n-6 PUFA 
(grapeseed oil), 35% fat provided 
from SFA c conut oil) and 20% 
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Al-Disi DA. et 
l., Nutri nts, 
2015 [45] 
92 lean controls (mean age 24 y), 24 overweight or 
obese (mean age 32 y) and 50 T2DM (mean age 42 
y) subjects, all women 
Serum LPS 
quantified by 
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High-fat meal (whipping cream
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and 6 g protein per m² body 
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controlled trial 
     LPS 3 h after high-fat 
meal in the lean 
(compa d to baseline) 
and T2DM (compared to 1 
h postprandi l) groups 
Vors C. et al., J 
Clin 
E docrinol 
Metab, 2015 
[36] 
8 normal-weight (mean ag  29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomize  
crossover study 
     LPS only in obese 
subjects after 40 g fat 
compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obe  
(mean age 44 y) subjects, all en 
Plas a LPS 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
LPS after mixed meal
compared to baseline
Vors C. et al., Lipids Health
Dis, 2017 [38]
8 normal-weight (mean age 29 y) and 8 obese (mean age 31 y) subjects,
all men
Plasma LPS
quantified by LAL Meals with emulsified or spread fat
Randomized
crossover study
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Lyte JM. et al., 
Lipids Health 
Dis, 2016 [37] 
20 healthy subjects (mean age 25 y, 60% men) 
Serum LPS
quantified by 
LAL 
Four meals (35% fat provided
from n-3 PUFA (fish oil), 35% fat 
provided from n-6 PUFA 
(grap seed oil), 35% fat provided 
from SFA (coconut oil) and 20% 
fat (olive oil, control diet)) 
Randomized 
single-blind 
crossover study 
 LPS until 5 h after n-3 
PUFA meal compared to 
SFA meal 
Al-Disi DA. et 
al., Nutrients, 
2015 [45] 
92 lean controls (mean ge 24 y), 24 overweight or 
obese (mean age 32 y) and 50 T2DM (mean age 42 
y) subjects, all women 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Randomized 
controlled trial 
     LPS 3 h after high-fat 
meal in the lean 
(compared to baseline) 
and T2DM (compar d to 1 
h postprandial) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in obese 
subjects after 40 g fat 
compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dos -
resp se of postprandial 
LPS betwe  normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS aft r high-fat di t 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
LPS after e ulsifi d fat
meal in obese subjects
compared to (i) spread fat and
(ii) emulsifi d r sprea fat in
normal-weight subjects
Abbreviations: LPS Lipopolysaccharide; LAL Limulus Amebocyte Lysat ; SFA Saturated fatty acids; MUFA monounsa urated fatty acids; PUFA polyunsaturated fatty acids; T2DM Type 2
Diabetes Mellitus; HOMA-IR Homeostasis model assessment of insulin resistance; TG Triglycerides; IGT impaired glucose toleranc .
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3.1.2. Associations between Long-Term Dietary Interventions and Circulating LPS
In an intervention study, the increase in energy intake (+70 g fat for eight weeks) was associated
with an acute rise in endotoxin levels in the postprandial state, but not in the fasting state [46] (Table 2).
More recently, three weeks of an intervention based on a low-fat high-carbohydrate diet enriched in
n-3 PUFA has been shown to increase the postprandial levels of LPS, but decrease the fasting levels of
LPS, compared with a Mediterranean diet enriched in MUFA or a SFA-rich diet, among healthy older
subjects [47]. Among 75 metabolically impaired subjects, adherence to a high-fat high-saturated-fatty
acid diet for 12 weeks led to an increase in the postprandial levels of LPS, but not the fasting levels [48].
In a crossover study among eight healthy older adults (55 y and over), Pendyala et al. [49]
demonstrated that following a Western-type diet for four weeks significantly increased fasting plasma
levels of LPS by 71%. In contrast, a 38% decrease in fasting plasma LPS levels was observed after
four weeks of adherence to a prudent-type diet with equivalent energy intake to the Western-type
diet. Regardless of the source of energy, Breusing et al. [50] observed that the 31% increase in fasting
endotoxemia after one week of overfeeding (+50% of the energy requirement) was reversed by three
weeks of caloric restriction (−50% of the energy requirement) among 15 healthy adults.
3.1.3. Associations between Lifestyle Dietary Patterns and Circulating LPS (Table 2)
Although of major interest, only very few studies have investigated the relationship between
usual diet and circulating levels of LPS, all using a cross-sectional design analysis and exhibiting
inconsistent results. In a subsample of 201 healthy men, fat and energy, but not carbohydrate or
protein, intake was positively associated with fasting levels of LPS [51]. More recently, Kallio et al. [52]
reported an association between energy intake and the levels of LPS observed only among lean subjects.
Surprisingly, no association between fat intake and the fasting levels of LPS was observed in this study.
On the other hand, two studies did not find an association between nutrient intake and fasting LPS
levels among overweight and obese pregnant women [53] or type 1 diabetes patients [54]. In this
latter study [54], higher consumption of fish and healthy snacks (including fruits and berries, fresh
vegetables, soft drinks, yoghurt and low-fat cheese) and higher adherence to a modern diet (composed
of fresh vegetables, pasta and rice, poultry, meat dishes and fried or grilled foods) were all significantly
associated with lower fasting LPS levels in serum [54]. Finally, among elderly patients with nonvalvular
atrial fibrillation, higher adherence to a Mediterranean-type diet was inversely correlated with fasting
circulating LPS levels [55]. Interestingly, among Mediterranean diet food components, higher intake of
fruits and legumes showed a major association with lower levels of LPS.
Overall, these results underlined that a transient rise in circulating levels of LPS can be induced
by a large variety of high-fat diets, especially those devoid of healthy food components. Moreover,
fasting or postprandial assessment of LPS could also partly explain the discrepancies observed in
several studies. Considering that exposure to an overload of endotoxins could contribute to the
development of adverse health outcomes such as elevated systemic inflammation, neuroinflammation,
neurodegeneration and neural death in experimental studies [15,56], we hypothesized that lifelong
exposure to endotoxins inherent to adherence to unhealthy diets and to ageing could worsen the
detrimental outcomes of endotoxemia. The second part of this state-of-the-art paper describes the
few studies focusing on the relationship between endotoxemia and cognitive disorders and dementia
in humans.
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Table 2. Selective evidence on the association between long-term diet and endotoxemia.
Clinical Trials
Reference Sample Characteristics atBaseline
Endotoxemia
Assessment Nutritional Assessment Analysis Design Results
Laugerette F. et al., Mol
Nutr Food Res, 2014 [46]
18 healthy subjects (mean age
31 y, all men)
Plasma LPS
quantified by LAL
Overfeeding with +70 g of lipids to the usual
daily diet with 46.3% from saturated fatty acids
during 8 weeks
Controlled trial
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Lyte JM. et al., 
Lipids Health 
Dis, 2016 [37] 
20 healthy subjects (mean age 25 y, 60% men) 
Serum LPS 
qua tified by 
LAL 
Four meals (35% fat provided 
from n-3 PUFA (fish oil), 35% fat 
provided from n-6 PUFA 
(grapeseed oil), 35% fat provided 
from SFA (coconut oil) and 20% 
fat (olive oil, control diet)) 
Randomized 
single-blind 
crossover study 
      LPS until 5 h after n-3 
PUFA meal compared to 
SFA meal 
Al-Disi DA. et 
al., Nutrients, 
2015 [45] 
92 lean controls (mean age 24 y), 24 overweight or 
obese (mean age 32 y) and 50 T2DM (mean age 42 
y) subjects, all women 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Randomized 
controlled trial 
     LPS 3 h after high-fat 
meal in the lean 
(compared to baseline) 
and T2DM (compared to 1 
h postprandial) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in obese 
subjects after 40 g fat 
compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
Postprandial levels of LPS
compared to baseline
No difference in fasting levels of LPS
after overfeeding period compared to
baseline
Breusing N. et al., J Am
Coll Nutr, 2017 [50]
15 healthy subjects (age 20–29 y,
all men)
Plasma LPS
quantified by LAL
Overfeeding (+50% of the energy requirement)
during 1 week, caloric restriction (−50% of the
energy requirement, 3.5% fat) during 3 weeks
and hyper-caloric refeeding (+50% of the energy
requirement) with either low- or high-glycemic
index diet during 2 weeks
Randomized
crossover study
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20 healthy subjects (mean age 25 y, 60% men) 
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2015 [45] 
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surface) 
Randomized 
controlled trial 
     LPS 3 h after high-fat 
meal in the lean 
(compared to baseline) 
and T2DM (compared to 1 
h postprandial) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in obese 
subjects after 40 g fat 
compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
Fasting levels of LPS after
overfeeding period (+30.8% compared
to baseline)
Normalization of fasting levels of LPS
levels with the caloric estriction diet
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PUFA m al compared to 
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Al-Disi DA. et 
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2015 [45] 
92 lean controls (mean age 24 y), 24 overweight or 
obese (mean age 32 y) and 50 T2DM (mean age 42 
y) subjects, all women 
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Vors C. et al., J 
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Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
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Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
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     LPS only in obese 
subjects after 40 g fat 
compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
Fasting levels of LPS after
hyper-caloric refeed g p riod (+24.7%
compared to baseline)
López-Moreno J. et al., J
Agric Food Chem, 2017
[48]
75 subjects with metabolic
syndrome (mean age 56 y)
Plasma LPS
quantified by LAL
Four diets (High-saturated-fatty acids diet
(HSFA, 38% fat with 16% SFA, 12% MUFA and
6% PUFA), High MUFA (HMUFA, 38% fat with
8% SFA, 20% MUFA and 6% PUFA), Low-fat
high complex carbohydrate (LFHCC, 28 fat)
and LFHCC n-3 supplemented with n-3 PUFA)
during 12 weeks
Randomized
controlled trial
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Lyte JM. et al., 
Lipids Health 
Dis, 2016 [37] 
20 healthy subjects (mean age 25 y, 60% men) 
Serum LPS 
quantified by 
LAL 
Four meals (35% fat provided 
from n-3 PUFA (fish oil), 35% fat 
provided fr m n-6 PUFA 
(grapeseed il), 35% fat provided 
from SFA (coconut oil) and 20% 
fat (olive oil, control diet)) 
Randomized 
single-blind 
crossover study 
      LPS until 5 h after n-3 
PUFA meal compared to 
FA m al 
Al-Disi DA. et
al., Nutrien s, 
2015 [45] 
92 lean controls (mean age 24 y), 24 overweight or 
obese (mean age 32 y) and 50 T2DM (mean age 42 
y) subjects, all women 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohy rate 
and 6 g protein per m² body 
surface) 
Randomized 
controlled trial 
     LPS 3 h after high-fat 
meal in the lean 
(compared to baseline) 
and T2DM (c mpared to 1 
h postprandial) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed m als containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in obese 
subjects after 40 g fat 
compared o 10 g fat
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean ge 41 y) and 18 ob se
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight an  bese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese ( ean age 40 y, 50  en), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
i  all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects comp red 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
Postprandial levels of LPS after
HSFA diet compared to baseline
No difference in postprandial LPS
levels after HMUFA, LFHCC and
LFHCC n-3 diets
No difference in fastin levels of LPS
between all 4 groups of diet after
intervention
López-Moreno J. et al.,
Exp Gerontol, 2018 [47]
20 healthy subjects (mean age
67 y, 50% men)
Plasma LPS
quantified by LAL
Mediterranean diet enriched in M with
virgin olive oil (38% fat) or SFA-rich diet (38%
fat) or low-fat high-carbohydrate diet enriched
in n-3 PUFA (CHO-PUFA diet, 30% fat)
during 3 weeks
Randomized
crossover study
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Lyte JM. et al., 
Lipids Health 
Dis, 2016 [37] 
20 healthy subjects (mean age 25 y, 60% men) 
Serum LPS 
quantified by 
LA  
Four meals (35% f t provided 
from n-3 PUFA (fish oil), 35% fat 
provided from n-6 PUFA 
(grapeseed oil), 35% fat provided 
from SFA (coconut oil) and 20% 
fat (olive oil, control diet)) 
Randomized 
single-blind 
crossover study 
      LPS until 5 h ft r n-3 
PUFA m al compare to 
SFA meal 
Al-Disi DA. t
al., Nutrients, 
2015 [ 5] 
92 lean controls (mean age 24 y), 24 overweight or 
obese (mean age 32 y) and 50 T2DM (mean age 42 
y) subjects, all women 
Serum LPS 
quantified by 
LA  
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body
surface) 
Randomized 
controlled trial 
     LPS 3 h after high-fat
meal in the lean 
(c mpared to baseline) 
and T2DM (compared to 1 
h postpr ndial) roups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in obese 
subjects after 40 g fat 
compared to 10 g fat 
Schwand r F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(me n ge 44 y) subj cts, all men 
Pl sma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal f a 
high-fat me l (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
Postprandial levels of LPS after
CHO-PUFA
No difference in postprandial levels of
LPS after Mediterranean diets enriched
in MUFA or SFA
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Lyte JM. et al., 
Lipids Health 
Dis, 2016 [37] 
20 healthy subjects (mean age 25 y, 60% men) 
Serum LPS 
quantified by 
LAL 
Four meals (35% fat pr vided 
from n-3 PUFA (fish oi ), 35% fat 
provided from n-6 PUFA 
(grapeseed oil), 35% fat provided 
from SFA (coconut oil) and 20% 
fat (olive oil, control diet)) 
Randomized 
single-blind 
crossover study 
      LPS until 5 h fter n-3 
PUFA meal compared to 
SFA meal 
Al-Disi DA. et 
al., Nutrients, 
2015 [45]
92 lean controls (mean age 24 y), 24 overweight or 
obese (mean age 32 y) and 50 T2DM (mean age 42 
y) subjects, all women 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface
Randomized 
controlled trial 
     LPS 3 h after high-fat 
meal in the lean 
(compar d to bas line) 
and T2DM (compared to 1 
h po tprandial) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 ormal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in obese 
subjects after 40 g fat 
compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
Fasting levels of LPS after
CHO-PUFA diet compared to
Mediterranean diets enriched in MUFA
r SFA
Pendyala S. et al.,
Gastroenterology, 2012
[49]
8 healthy subjects (mean age 60 y,
38% men) hospitalized
for the study
Plasma LPS
quantified by a
neutrophil
pri i g method
Western-type diet (40% fat with 20.8% from
saturated fat, 20% protein and 40%
carbohydrates) or Prudent-type diet (20% with
5.8% fro saturated fat, 20% protein and 60%
carbohydrates) during 1 month
Randomized
crossover study
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Lyte JM. et al., 
Lipids Health 
Dis, 2016 [37] 
20 healthy subjects (mean age 25 y, 60% men) 
Serum LPS 
quantified by 
LAL 
Four meals (35% fat provided 
from n-3 PUFA (fish oil), 35% fat 
provided from n-6 PUFA 
(grapeseed oil), 35% fat provided 
from SFA (coconut oil) and 20% 
fat (olive oil, control diet)) 
Randomized 
single-blind 
crossover study 
      LPS until 5 h after n-3 
PUFA meal compared to 
S  meal 
Al-Disi DA. et 
al., Nutrients, 
2015 [45] 
92 lean controls (m an age 24 y), 24 overweight or 
obese (mean ge 32 y) and 50 T2DM (mean age 42 
y) subjects, all women 
S um LPS 
qu ntified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Randomized 
controlled trial 
     LPS 3 h after high-fa
e l in he lean 
(co pared to baseline) 
and T2DM (compared to 1 
h postprandial) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in obese 
subjects after 40 g fat 
compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
Fasting levels of LPS after
Western-t pe diet
(+71% compared to baseline)
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Lyte JM. et al., 
Lipids Health 
Dis, 2016 [37] 
20 healthy subjects (mean age 25 y, 60% men) 
Serum LPS 
quantified by 
LAL 
Four meals (35% fat provided 
from n-3 PUFA (fish oil), 35% fat 
provided from n-6 PUFA 
(grapeseed oil), 35% fat provided 
from SFA (coconut oil) and 20% 
fat (olive oil, control diet)) 
Randomized 
ingle-bl nd 
 t  
      LPS until 5  after n-3 
PUFA meal compared to 
SFA meal 
Al-Disi DA. et 
al., Nutrients, 
2015 [45] 
92 lean controls (mean age 24 y), 24 overweight or 
obese (mean age 32 y) and 50 T2DM (mean age 42 
y) subjects, all women 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Randomized 
controlled trial 
     LPS 3  after hi h-fat 
e l in the lean 
(compared to baseline) 
and T2DM (compared to 1
h postprandial) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS nly in obese 
subjects after 40 g f t 
compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with ene gy intake 
in both groups  
No difference in the dose-
response of postprand al 
LPS between n rm l-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean ag  40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS a ter high-fat diet 
in all four roups 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
Fasting levels of LPS after
prudent-ty e diet
(−38% compar d to baseline)
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Table 2. Cont.
Observational Studies
Reference Sample Characteristics atBaseline
Endotoxemia
Assessment Nutritional Assessment Analysis Design Results
Amar J. et al., Am J Clin
Nutr, 2008 [51]
130 subjects below the LPS
detection threshold (mean age
55 y), 44 subjects between
9–39 U/mL (mean age 54 y) and
27 subjects under 39 U/mL (mean
age 53 y), all healthy men
Plasma LPS
quantified by
Kinetic-QCL TM
test
3 days of food-record diary Cross-sectional
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Lyte JM. et al., 
Lipids Health 
Dis, 2016 [37] 
20 healthy subjects (mean age 25 y, 60% men) 
Serum LPS 
quantified by 
LAL 
Four meals (35% fat provided 
from n-3 PUFA (fish oil), 35% fat 
provided from n-6 PUFA 
(grapeseed oil), 35% fat provided 
from SFA (coconut oil) and 20% 
fat (olive oil, control diet)) 
Randomized 
single-blind 
crossover study 
      LPS until 5 h after n-3 
PUFA meal compared to 
SFA meal 
Al-Disi DA. et 
al., Nutrients, 
2015 [45] 
92 lean controls (mean age 24 y), 24 overweight or 
obese (mean age 32 y) and 50 T2DM (m an age 42 
y) subjects, all women 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Randomized 
controlled trial 
     LPS 3 h after high-fat 
meal in the lean 
(compared to baseline) 
and T2DM (compared to 1 
h postprandial) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in obese 
subjects after 40 g fat 
compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
Fasting levels of LPS with fat and
total energy intake
Kallio KA. et al., Acta
Diabetol, 2015 [52]
2452 subjects (mean age 52 y) Serum LPS
quantified by LAL
24 h dietary recall Cross-sectional
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Lyte JM. et al., 
Lipids Health 
Dis, 2016 [37] 
20 healthy ubjects (mean age 25 y, 60% men) 
Serum LPS 
quantified by 
LAL 
Four meals (35% fat provided 
from n-3 PUFA (fish oil), 35% fat 
provided from n-6 PUFA 
(grapeseed oil), 35% fat provided 
from SFA (coconut oil) and 20% 
fat (olive oil, control diet)) 
Randomized 
single-blind 
crossover study 
      LPS until 5 h after n-3 
PUFA meal compared to 
SFA meal 
Al-Disi DA. et 
al., Nutrients, 
2015 [45] 
92 lean controls (mean age 24 y), 24 overweight or 
obese (mean age 32 y) and 50 T2DM (mean age 42 
y) subjects, all women 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Randomized 
controlled trial 
     LPS 3 h after high-fat 
meal in the lean 
(compared to baseline) 
and T2DM (compared to 1 
h postprandial) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in obese 
subjects after 40 g fat 
compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
Fasting levels of LPS with total
energy intake in lean healthy subjects
No significant association between
fasting levels of LPS an fat intake, and
among subjects with obesity, metabolic
syndrome, diabetes or coronary heart
disease
Röytiö H. et al., Br J Nutr,
2017 [53]
88 overweight pregnant women
(mean age 30 y)
Serum LPS
quantified by LAL
Three groups based on 3 days of food-record
diary (low fibre (<25 g/j) and moderate fat intake
(25–40%) n = 57, high fibre (>=25 g/j) and
moderate fat intake (25–40%) n=18 and low fibre
(<25 g/j) and high fat intake (>=40%) n = 13)
Cross-sectional
No significant association between
fasting levels of LPS and fat intake
No difference in fasting levels of LPS
levels among the three diet groups
Ahola AJ. Et al., Sci Rep,
2017 [54]
668 patients with type 1 diabetes
(mean age 45 y, 44% men)
Serum LPS
quantified by LAL
Food frequency questionnaire and3 days of
food-records diary Cross-sectional
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      LPS until 5 h after n-3 
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SFA meal 
Al-Disi DA. et 
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2015 [45] 
92 lean controls (mean age 24 y), 24 overweight or 
obese (mean age 32 y) and 50 T2DM (mean age 42 
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quantified by 
LAL
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and 6 g protein per m² body 
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(comp red to baseline) 
and T2DM (compared to 1 
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Endocrinol 
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8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
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Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in bese 
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compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
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     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
Fasting levels of LPS with higher
adherence score of fish, healthy snack
and modern diets
No difference in fasting levels of LPS
levels for sweet, ch es , vegetable or
traditional di ts
No difference in fasting levels of LPS
levels for nergy, acronutrients and
fibre intake
Pastori D. et al., J Am
Heart Assoc, 2017 [55]
704 pati nts with nonvalvular
atrial fibrillation treated by
vitamin K antagonists (mean age
74 y, 57% men)
Serum LPS
quantified by
ELISA
Short food frequency questionnaire Cross-sectional
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with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
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controlled trial 
     LPS 3 h after high-fat 
meal in the lean 
(compared to baseline) 
and T2DM (compared to 1 
h postprandial) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in obese 
subjects after 40 g fat 
compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-w ight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
Fasting levels of LPS with higher
adherence to a Mediterranean diet
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from n-3 PUFA (fish oil), 35% fat 
provided from n-6 PUFA 
(grapeseed oil), 35% fat provided 
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crossover study 
      LPS until 5 h after n-3 
PUFA meal compared to 
SFA meal 
Al-Disi DA. et 
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2015 [45] 
92 lean controls (mean age 24 y), 24 overweight or 
obese (mean age 32 y) and 50 T2DM (mean age 42 
y) subjects, all women 
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High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Randomized 
controlled trial 
     LPS 3 h after high-fat 
meal in the lean 
(compared to baseline) 
and T2DM (compared to 1 
h postprandial) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in obese 
subjects after 40 g fat 
compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 i paired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
Fasting levels of LPS with higher
consu ption of fruits and legumes
No difference in fasting levels of LPS
levels for the consumption of olive oil,
vegetables, fish, wine, m at and bread
Abbreviations: AD Alzheimer’s Disease; LPS Lipopolysaccharide; LAL Limulus Amebocyte Lysate; SFA Saturated fatty acids, MUFA monounsaturated fatty acids, PUFA polyunsaturated
fatty acids.
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3.2. LPS, Cognitive Disorders and Dementia
3.2.1. LPS Injection and Short-Term Cognitive Function Assessment in Interventional Studies
In the field of LPS-related inflammation in association with dementia or cognitive performances,
few studies have been identified following our research strategy.
First, all studies were interested in the impact of LPS injection on the inflammatory response of
the host. Transient increases in pro-inflammatory cytokines (for instance IL-6 and TNFα, on average
between 1 and 6 h post-infection) followed by the release of anti-inflammatory cytokines (for instance
IL1-Ra and IL-10, on average between 3 and 8 h post-infection), were observed after LPS injection in all
intervention studies. This result was consistent regardless of the LPS dose injected. Second, several
lines of evidence suggested that inflammatory cytokines such as IL-6 or TNFα could be involved in
cognitive disturbances [26,27]. However, it remains unknown whether and to what extent cognitive
functions could be affected during transient immune activation induced by a single injection of LPS, as
provided by the selected intervention studies described below (Table 3).
In a crossover study, Reichenberg et al. [57] reported a significant impairment in declarative
memory until 10 h after the injection of LPS. With this intervention, decreased performances in
declarative memory have also been observed in a subsample of subjects, as well as improvements
in working memory compared to the injection of placebo [58]. These last controversial results are,
however, not generalizable to the whole study sample [57], which raises questions. Finally, in both
studies [57,58], there were no statistical or clinical differences regarding attention or executive functions
following the injection of LPS compared to placebo.
In another study, using an injection of a lower dose of LPS (0.2 ng/kg body weight) a negative
correlation was found between the increased IL-6 levels and memory and learning performance after
4.5–6 h [59]. Among all results, the injection of LPS did not alter working or executive functions or
attention among young healthy volunteers. With higher doses of LPS (2 ng/kg body weight), the results
are also controversial. This treatment did not induce any alteration of working memory, psychomotor
speed capacity and information processing ability, fine control motor and attention performances
until 10 h post-injection compared with the placebo group [60]. Surprisingly, the authors observed an
increase in attention performance in the treated group compared to the placebo group.
In 2010, Grigoleit et al. [61] found that the injection of LPS did not affect the subscales of the
Wechsler Memory Scale, analysing performances in verbal, visual or delayed memory, as well as
attention and executive control processes. Using a double-blind crossover study, the same authors [62]
observed that LPS injection did not affect accuracy in working memory performance, but improved
reaction time in the high-dose (0.8 ng/kg body weight) 2 h post-injection compared to placebo; a result
that was not observed with the lowest LPS dose (0.4 ng/kg body weight).
Alteration in emotional/social processing was observed following the injection of LPS at 0.8 ng/kg
body weight [63], but not with a lower dose of LPS (0.4 ng/kg body weight) [64].
Altogether, these results underlined that the LPS dose, the delay and the targeted samples
have different responses on the cognitive performances assessed (themselves being heterogeneous
between studies), which deserves further research with emphasis on both experimental conditions
and outcomes.
3.2.2. Endotoxemia and HIV-Associated Neurocognitive Disorders in Observational Studies
In the field of LPS and cognition, we identified 2 cross-sectional observational studies on
non-healthy individuals, focusing on HIV-infected participants with or without HIV-associated
neurocognitive disorders (HAND) [65,66] (Table 3). The median fasting levels of LPS were higher
among the HAND group than among the no-HAND participants (116.1 ρg/mL vs. 98.2 ρg/mL) [65].
Interestingly, circulating levels of LPS were not associated with the severity of HAND. In the other study,
plasma LPS levels did not differ according to the score of a neurocognitive test battery designed to assess
several domains of cognitive function (i.e., motor skills, speed of information processing, attention,
Nutrients 2019, 11, 1887 12 of 23
learning, memory, language fluency and executive function) [66]. More recently, Jespersen et al. [67]
reported a lack of association between fasting levels of LPS and markers of axonal damage or monocyte
activation in the central nervous system among HIV-infected adults without evidence of impaired
cognitive function. In this specific sample, LPS was not detectable in the cerebrospinal fluid.
Although not tested in a human model of endotoxemia, repeated lifelong exposure to endotoxin
may lead to a long-term alteration in all cognitive domains. Dementia diagnosis is the result of a long
insidious process where cognitive disorders evolve to pathology. However, the relationship between
endotoxemia and dementia has been explored in very few studies, which are described below (Table 4).
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Table 3. Selective evidence on the association between lipopolysaccharides and cognitive function.
Clinical Trials
Reference Sample Characteristics atBaseline
Endotoxemia
Assessment Outcomes Study Design Results
Krabbe KS. et al., Brain
Behav Immun, 2005 [59]
12 healthy subjects
(mean age 26 y, all men)
Injection of LPS
E. coli 0.2 ng/kg or
placebo
Memory and learning (Word-list memory test)
Working memory (Digit Span backward and
Letter–Number Sequencing)
Attention (Digit span forward and Digit symbol)
Executive functions (Trail Making Test A and B)
Assessment before and at 1.5, 6 and 24 h
post-injection
Randomized
double-blind
crossover study
Negative correlation between IL-6 at
4.5 and 6 h post-injection and the
word-list learning performance
LPS injection did not affect
performance on other cognitive tests
Kullmann JS et al., Soc Cogn
Affect Neurosci, 2014 [64]
18 healthy subjects
(mean age 26 y, all men)
Injection of LPS
E. coli 0.4 ng/kg or
placebo
Emotional/social processing
(Reading the mind in the eye)
Brain activation during the test
Assessment at 2 h post-injection
Randomized
double-blind
crossover study
LPS injection did not affect the number
of correct responses during the
Reading the mind in the eye test
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20 healthy subjects (mean age 25 y, 60% men) 
Serum LPS 
quantified by 
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Four meals (35% fat provided 
from n-3 PUFA (fish oil), 35% fat 
provided from n-6 PUFA 
(grapeseed oil), 35% fat provided 
from SFA (coconut oil) and 20% 
f t (oliv  oil, control diet)) 
Randomized 
single-blind 
crossover study 
      LPS until 5 h after n-3 
PUFA meal compared to 
SFA meal 
Al-Disi DA. et 
al., Nutrients, 
2015 [45] 
92 lean controls (mean age 24 y), 24 overweight or 
obese (mean age 32 y) and 50 T2DM (mean age 42 
y) subjects, all women 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Randomized 
controlled trial 
     LPS 3 h after high-fat 
meal in the lean 
(compared to baseline) 
and T2DM (compared to 1 
h postprandial) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in obese 
subjects after 40 g fat 
compared to 10 g fat 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
Responses in the fusiform gyrus,
temporo-parietal junction, superior
temporal gyrus and precuneus regions
compared to placebo
Grigoleit JS. et al.,
Neurobiol Learn Mem, 2010
[61]
24 healthy subjects
(mean age 25 y, all men)
Injection of LPS
E. coli 0.4 ng/kg or
placebo
Attention and executive functions (Color word
stroop task (assessment before and 1.5 h
post-injection))
Verbal, visual and delayed memory (Revised
Wechsler Memory Scale (assessment at 3 h
post-injection))
Randomized
double-blind
controlled trial
LPS injection did not affect
performance on cognitive tests
Grigoleit JS. et al., PLoS
One, 2011 [62]
18 healthy subjects in the low-dose
group (LPS 0.4 ng/kg) and 16
subjects in the high-dose group
(LPS 0.8 ng/kg), mean age 25 y
Injection of LPS
E. coli 0.4 ng/kg or
placebo, or LPS
E. coli 0.8 ng/kg or
placebo
Working memory (N-back task)
Assessment at 1.75 and 3 h post-injection
Randomized
double-blind
crossover study
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provided from n-6 PUFA 
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crossover study 
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PUFA meal compared to 
SFA meal 
Al-Disi DA. et 
al., Nutrients, 
2015 [45] 
92 lean controls (mean age 24 y), 24 overweight or 
obese (mean age 32 y) and 50 T2DM (mean age 42 
y) subjects, all women 
Serum LPS 
quantified by 
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High-fat meal (whipping cream 
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and 6 g protein per m² body 
surface) 
Randomized 
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     LPS 3 h after high-fat 
meal in the lean 
(comp r d to baseline) 
and T2DM (compared to 1 
h postprandial) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-w ight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
crossover study 
     LPS only in obese 
subjects after 40 g fat 
c mpared to 10 g f t 
Schwander F. 
et al., J Nutr, 
2014 [35] 
19 normal-weight (mean age 41 y) and 18 obese 
(mean age 44 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
500, 1000 and 1500 kcal of a 
high-fat meal (61% fat) 
Randomized 
crossover study 
     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
Reaction time in N-back task in
the high-dose group compared to
pl cebo
LPS did not affect the accuracy in
N-back task
Moieni M et al., Brain
Behav Immun, 2015 [63]
109 healthy subjects (mean age 24 y,
40% men): 58 subjects in the LPS
i jection group and 51 in the
placebo group
Injection of LPS
E. coli 0.8 ng/kg or
placebo
Emotional/social processing (Reading the mind in
the eye)
Assessment at 1 h 40 post-inj ction
Randomized
double-blind
controlled trial
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high-fat meal (61% fat) 
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     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
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     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
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quantified by 
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Number of correct responses in
the LPS group
Reichenberg A. et al., Arch
Gen Psychiatry, 2001 [57]
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(mean age 24 y, all men)
Injection of LPS
Salm lla
abortus equi 0.8
ng/kg or placebo
Declarative memory (Story recall, Figure recall and
Word-list learning)
Attention (Digit span forward,
Digit symbol, Ruff 2 and 7 cancellation test, Simple
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Executive functions (Colored Trail Making Test A
and B and Word fluency test)
Assessment at 1–2, 3–4 and 9–10 h post-injection
Randomized
double-blind
crossover study
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meal in the lean 
(compared to baseline) 
and T2DM (compared to 1 
h postprandial) groups 
Vors C. et al., J 
Clin 
Endocrinol 
Metab, 2015 
[36] 
8 normal-weight (mean age 29 y) and 8 obese 
(mean age 31 y) subjects, all men 
Plasma LPS 
quantified by 
LAL 
Mixed meals containing 10 or 40 
g fat (69% SFA, 28% MUFA and 
3% PUFA) 
Randomized 
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High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
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Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
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figure rec ll and word-list learning
tests compared to p acebo at 1–2, 3–4
and 9–10 h post-injection
LPS injection did n t affect
performance on other cognitive tests
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Table 3. Cont.
Clinical Trials
Reference Sample Characteristics atBaseline
Endotoxemia
Assessment Outcomes Study Design Results
Cohen O. et al., J Mol
Neurosci, 2003 [58]
10 healthy subjects (sub-sample of
the Reichenberg’s study [57])
Injection of LPS
Salmonella
abortus equi
0.8 ng/kg or
placebo
Declarative memory (Story recall)
Working memory (Digit span backward)
Attention (Digit span forward and
Ruff 2 and 7 cancellation test)
Assessment at 1–2, 3–4 and 9–10 h post-injection
Randomized
double-blind
crossover study
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Performance on story recall
compared to placebo at 1–2, 3–4 and
9–10 h post-injection
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(mean age 44 y) subjects, all men 
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500, 1000 and 1500 kcal of a 
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No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
LAL 
High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
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crossover study 
No difference in LPS 
levels after high-fat diet 
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Performance digit span backward
test compared to placebo at 1–2, 3–4
and 9–10 h post-injection
LPS injection di not affect
perf rmance on other cognitive tests
Van den Boogaard M. et al.,
Crit Care, 2010 [60]
15 healthy subjects in the injection
group (mean age 23 y, all men) and
10 healthy controls
(mean age 25 y, all men)
Injection of LPS
E. coli 2 ng/kg or
no injection
Working memory (Digit span backward)
Attention (Digit span forward, Color word stroop
task and Paced Auditory Serial Addition Test
(PASAT))
Psychomotor speed capacity and information
processing ability (number of correct response on
the Digit symbol test)
Fine control motor (time required to finish the
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Assessment at 1–2, 3–4 and 9–10 h post-injection
Single-blind trial
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     LPS with energy intake 
in both groups  
No difference in the dose-
response of postprandial 
LPS between normal-
weight and obese 
Harte AL. et 
al., Diabetes 
Care, 2012 [43] 
9 non-obese (mean age 40 y, 50% men), 15 obese 
(mean age 44 y, 50% men), 12 impaired glucose 
tolerance (IGT, mean age 42 y, 58% men) and 18 
T2DM (mean age 45 y, 61% men) subjects 
Serum LPS 
quantified by 
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High-fat meal (whipping cream 
with 75 g fat, 5 g carbohydrate 
and 6 g protein per m² body 
surface) 
Controlled trial 
     LPS after high-fat diet 
in all four groups 
compared to baseline 
     LPS by 20% in obese 
and IGT and by 125% in 
T2DM subjects compared 
to non-obese participants 
Milan AM. et 
al., Nutrients, 
2017 [42] 
15 young adults (mean age 23 y, 40% men) and 15 
elderly subjects (mean age 67 y, 40% men)  
Plasma LPS 
quantified by 
LAL 
High-fat (32% fat) or low-fat 
(11.5% fat) meals 
Randomized 
crossover study 
No difference in LPS 
levels after high-fat diet 
compared to baseline 
Performance n PASAT test
compared to control groupLPS
injection did not affect performance on
other cognitiv tests
Observational studies
Reference Sample characteristics at baseline Endotoxemiaassessment Outcomes Study design Results
Lyons JL. et al., J Acquir
Immune Defic Syndr, 2011
[66]
97 HIV-infected patients (mean age
47 y, 76% men)
Plasma LPS
quantified by LAL
HIV-associated neurocognitive disorders (HAND)
Global T test (motor skills, speed of information
processing, attention (working memory), learning
(memory encoding), memory (memory recall),
language fluency, and executive function)
Cross-sectional
LPS levels id not differ according to
the seve ity f HAND
LPS levels di not differ in subjects
with global impairment (Global T test <
40) compar d to unimpaired subjects
Vassallo M. et al., J
Neurovirol, 2013 [65]
40 HIV-infected patients with
HIV-associated neurocognitive
disorders (HAND) (median age
46 y, 78% men) an 139
HIV-infected patients without
HAND (median age 44 y, 72% n)
Plasma LPS
quantified by LAL
HIV-associated neurocognitive disorders (HAND)
z-score (learning
and recall episodic memory, attention/concentration,
working me ory, executive functions, language,
visual ag osia and motor/psychomotor speed)
Cross-sectional
LPS levels was i er in the HAND
group compared to no-HAND group
LPS levels id not differ according to
the severity of HAND
Jespersen S. et al., BMC
Infect Dis, 2016 [67]
62 untreated HIV-infected p tients
without evidence of impaired
cognitive function (mean age 39 y,
52% men)
Plasma and CSF
LPS quantified by
LAL
CSF neurofilament light chain protein (marker of
CNS axonal damage) and CSF neopterin (marker of
monocyte activation)
Cross-sectional
No association between plasma LPS
and CSF neurofilament light chain
protein or CSF neopterin
LPS was not detectable in CSF
Abbreviations: AD Alzheimer’s Disease; LPS Lipopolysaccharide; LAL Li ulus Amebocyte Lysate; HIV Human Immunodeficiency Vi u es; HAND HIV-associated neurocognitive
disorders; CSF Cerebrospinal Fluid; CNS Central Nervous System; NFL Neurofilament light chain protein.
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3.2.3. Endotoxemia and Alzheimer’s Disease or Dementia Diagnosis in Observational Studies
First, we identified two studies interested in the anatomy of the brain in post-mortem patients.
Recent investigations reported higher LPS abundance in grey matter (superior temporal gyrus lobe)
and white matter (frontal lobe) in brains from patients with Alzheimer’s disease (AD) than in those
from participants free of dementia [68]. Of greater interest, LPS colocalized with Aβ1-40/42 in amyloid
plaques and with Aβ1-40/42 around blood in AD brains [68]. Another study reported an average
three-fold higher abundance of in the hippocampus—an anatomical region of the AD brain that
develops the earliest and most profound neuropathology—from four AD brains compared to two
age-matched control brains, as well as a two-fold higher abundance in neocortical extracts from six AD
brains and six age-matched control brains [69]. In some advanced AD patients (criteria not defined in
the study), hippocampal brain lysate exhibited up to a 26-fold increase in LPS [69].
In 2008, Ancuta et al. [70] observed that plasma LPS levels were significantly higher among
dementia-associated HIV participants than among participants without neurocognitive impairment,
independent of plasma viral load and CD4 counts. Surprisingly, LPS levels in participants with
minor cognitive and motor disorders, asymptomatic neurocognitive impairments or neuropsychiatric
impairments did not differ from those in participants without neurocognitive impairment. Finally, the
last study we identified reported that plasma LPS levels were three-fold higher in 18 AD participants
(mean 61 ρg/mL) than in 18 healthy controls (mean 21 ρg/mL) [71].
Altogether, the scarce available literature in this field suggests that higher LPS levels are observed
(i) among the brains of AD patients, in several regions of interest and (ii) among living AD participants,
and that these results could be partially explained by higher immunosenescence also among HIV
patients. These results allow us to speculate that not only transient immune activation induced by LPS,
as described earlier, but also increased fasting levels of LPS (from different sources) could be partly
involved in the pathogenesis of dementia. Longitudinal studies are still required to test this hypothesis.
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Table 4. Selective evidence on the association between lipopolysaccharides and dementia.
Alzheimer’s Disease Brain Samples
Reference Sample Characteristics at Baseline EndotoxemiaAssessment Outcomes Study Design Results
Zhan X. et al.,
Neurology, 2016 [68]
24 AD brains (mean age 77 y, 38%
men, median Braak stage: 6) and 18
age-matched controls brains (mean
age 81 y, 56% men, median Braak
stage: 2)
LPS E. coli antibodies
and E. coli K99 pili
protein
Superior temporal gyrus from
grey matter (GM) and frontal lobe
from white matter (WM)
Cross-sectional
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and LPS levels in GM and
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Front Cell Infect
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10 AD brains (mean age 74 y) and 8
controls brains (mean age 73 y), all
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4. Discussion
The hypothesis tested in this “state-of-the-art” paper was that metabolic endotoxemia could be an
underlying mechanism of the relationship between nutrition (and mainly fats intake) and age-related
cognitive impairments.
First, to the best of our knowledge, there was no study focusing on this whole association (i.e.,
nutritional habits that could modulate endotoxemia, which itself could be part of the pathological
processes leading to dementia) in a single sample setting. Therefore, we conducted two approaches,
based on the available literature: we synthesized studies focusing (i) on the role of nutritional habits
and interventions on the modulation of metabolic endotoxemia, and (ii) on the association between
endotoxemia and cognitive impairments.
To some extent, overall metabolic endotoxemia may be attributed to a balance between the number
of LPS-containing Gram-negative bacteria in the gut microbiota and the subsequent translocation of
the LPS across the gastro-intestinal barrier into the bloodstream; the fat content of the diet being a
putative key actor of this translocation.
Our synthesis provided convincing evidence that fat-rich meals have an undoubted capacity to
transiently modulate postprandial metabolic endotoxemia in humans. Indeed, recent studies have
demonstrated that fat absorption and digestion is a step where dissociated LPS can be incorporated into
chylomicrons (i.e., lipoproteins responsible for the transport of lipids through the gut barrier) thereby
enabling their translocation into the bloodstream [21,22]. We highlighted that not only the quantity but
also the quality of dietary fats may influence metabolic endotoxemia. Precisely, imbalanced diets in
favour of saturated fatty acids have been associated with higher postprandial levels of LPS while a
combination of these diets with other healthy nutritional components, such as fibre [41], is able to limit
this increase.
On the other hand, long-term consumption of a high-energy-density diet, especially those derived
from fat, has been associated with gut microbiota dysbiosis [72]. By shifting the balance in favour of,
or at the expense of, LPS-containing Gram-negative bacteria, diet could also contribute to the amount
of LPS in the gut and their translocation into the bloodstream. Metabolic diseases such as obesity and
T2DM are often associated with gut microbiota dysbiosis [73,74], most likely worsened by lifelong
consumption of an unhealthy fat-rich diet. This latter result could explain, at least in part, the results
reporting increased fasting levels of LPS and an exacerbated postprandial increase of LPS following a
high-fat-saturated meal in metabolically impaired individuals compared to healthy individuals.
Moreover, gut dysbiosis, and the subsequent release of LPS can be managed by several dietary
factors, that are not discussed in the present paper, including, for instance, the intake of refined sugars,
alcohol or nutritional supplements with pre- and probiotics for details see, [19]. In particular, high
consumption of glucose or fructose, which is part of the Western diet, could induce an increase in
circulating levels of LPS in mice [75]. Pronounced intestinal permeability and increased plasma levels
of LPS were found in patients with chronic alcohol abuse [76]. Pre- and probiotics have demonstrated
the ability to manipulate gut microbiota and to influence the circulating levels of LPS [19]. However,
we did not intend to review all potential and nutritional factors that might increase levels of LPS and
prefer to limit our hypothesis to lipids, which is a well-known risk factor for AD [77].
As a limitation of the selected studies, the discrepancies observed between postprandial and
fasting levels of circulating LPS after dietary interventions are questionable. These observations suggest
that metabolic endotoxemia has a fluctuating nature in humans, and that fasting levels of LPS may
therefore not be an accurate marker of chronic exposure to endotoxins over time. Some authors have
also suggested the measurement of LBP, which is considered a longer-term marker of endotoxin-related
exposure than LPS [78,79].
The main consequence of chronic exposure to endotoxemia is the onset and maintenance of a
low-grade inflammation state, with associated deleterious outcomes in elderly individuals [26,27].
However, it remains unclear to what extent acute exposure to LPS could induce age-related cognitive
disorders. Indeed, our literature research showed no convincing evidence that exposure to an
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intravenous overload of endotoxins was associated with major cognitive alterations in healthy
individuals; a result that is in line with a previous review [80]. As already mentioned, the large
heterogeneity of interventional studies reported in this paper (i.e., in terms of the injected doses of LPS,
the neurocognitive tests used to assess short-term cognitive performances or the various delays between
injection of LPS and cognitive assessment, for instance) limits us in drawing definitive conclusions
regarding the association between endotoxemia and cognitive performances. Additionally, speculative,
controversial results of LPS injection on some selected cognitive tests also ask for questions on possible
compensatory mechanisms, which deserves further research.
Regarding the association between endotoxemia and dementia, the results seem to be more
consistent, while they are based on a very small number of studies. Dementia results in a long
insidious process accompanied by molecular and physiological changes, including oxidative stress,
impairment in neuronal function and the death of neuronal cells, which may be caused or worsened
by neuroinflammation [26,81]. We thought that accumulated lifelong exposure to endotoxin may
therefore be associated with more severe stages of cognitive disorders and dementia. Due to the lack
of prospective studies to support this hypothesis, we cannot exclude a possible reverse causation. For
instance, individuals with advanced stages of dementia are more likely to develop bacterial infections
(i.e., in part due to a lack of hygiene inherent to the deterioration of cognitive performances and
disability status) and therefore to be exposed to higher endotoxemia. In addition, and inherent to
ageing, increased permeability in physiological barriers (i.e., intestinal and blood-brain barriers) is
observed in AD individuals [82,83], which could also promote the translocation of higher amounts of
neurotoxic molecules such as LPS.
Finally, the LPS doses used in most interventional studies may also be discussed, in addition to
those of natural exposure pathways which may gradually and intermittently deliver smaller amounts
of endotoxin over time.
Among the limitations of this state-of-the-art paper, we acknowledge the lack of adopting a
strict systematic literature review methodology. However, only partial studies have been identified
to respond to our whole hypothesis which confirmed our innovative approach. As a limitation, we
cannot exclude a publication bias; studies that are not statistically significant have been available more
often than those with significant results. The strengths of the present analysis are therefore to update,
by a holistic approach, in a single article the experimental and observational literature in the field of
fat-rich nutrition, endotoxemia and cognition in humans and to identify some gaps to be completed in
the near future.
5. Conclusions
Nutrition has been proposed as a promising non-medical strategy to prevent cognitive decline and
subsequent dementia. Affected by the quantity and the quality of ingested fats, metabolic endotoxemia,
involving a potent pro-inflammatory response of the host, could be one of the underlying mechanisms.
As the postprandial state represents a stressful condition in which our current society spends most of
its time, the identification of an individual-adapted dietary pattern associated with lower metabolic
endotoxemia and subsequent inflammation is a promising area for future research focusing on
inflammatory-associated diseases. However, there is an important need for research to understand
to what extent transient but also chronic low-exposure to LPS, through repeated measurements of
postprandial and fasting levels of LPS over time, could be associated with long-term cognitive changes
until the diagnosis of dementia.
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